Healthcare Provider Webinar: Biologics & Biosimilars – An Overview for Healthcare Providers In the treatment of osteoporosis, biologic and biosimilar medications may be provided as part of a treatment plan. […]

Latest News PHAC Osteoporosis Key Findings August 18, 2021 Osteoporosis Canada has been working closely with the Public Health Agency of Canada (PHAC) over the past few years assisting in […]

This report provides a national overview on diagnosed osteoporosis, related fractures and the osteoporosis care gap among Canadians 40 years and older.  It reports on administrative data from the Canadian […]

Bisphosphonate therapy – long term use Recently a study published by Drieling et al in JAGS 2017 described the results of a cohort study of 5120 older women with an […]

Bisphosphonate therapy – long term use Recently a study published by Drieling et al in JAGS 2017 described the results of a cohort study of 5120 older women with an […]

Since the COVID-19 lockdown began and even now as things begin to open up across the country, many health professionals have been consulting with their patients on-line or on the […]

Osteoporosis Canada’s Quality Standards for Fracture Liaison Services in Canada were developed to support implementation of effective FLS. They provide clear guidance for healthcare professionals and administrators on what an effective FLS […]

Denosumab (Prolia) has been shown to reduce the risk of fracture in postmenopausal women and men ≥50 years old with osteoporosis. It has also been approved for steroid induced bone […]

Available Volunteer Opportunities Bone Health Education Presenter – Virtual Bone Health Education Volunteers work together with the Community Engagement Coordinators and are an integral part in the planning and facilitating […]